Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV.
Lee YL, Lin KY, Cheng SH, Lu PL, Wang NC, Ho MW, Yang CJ, Liou BH, Tang HJ, Huang SS, Huang SH, Chen TC, Lin CY, Lin SP, Lee YT, Hung CC; Taiwan HIV Study Group.
Lee YL, et al. Among authors: lin cy, lin ky, lin sp.
Int J Antimicrob Agents. 2021 Sep;58(3):106403. doi: 10.1016/j.ijantimicag.2021.106403. Epub 2021 Jul 18.
Int J Antimicrob Agents. 2021.
PMID: 34289404